You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monophosphoryl lipid A

Showing 1 - 25 of 3,367
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type I Hypersensitivity Trial in Mississauga (RagweedMATAMPL, Placebo)

Withdrawn
  • Type I Hypersensitivity
  • RagweedMATAMPL
  • Placebo
  • Mississauga, Ontario, Canada
    Allied Research International Inc.
Aug 5, 2021

Type I Hypersensitivity Trial in Mississauga (Grass MATA MPL)

Completed
  • Type I Hypersensitivity
  • Grass MATA MPL
  • Mississauga, Ontario, Canada
    Allied Research International Inc.
Jul 7, 2021

Type I Hypersensitivity Trial in Mississauga, Ottawa (Grass MATAMPL)

Completed
  • Type I Hypersensitivity
  • Grass MATAMPL
  • Mississauga, Ontario, Canada
  • +2 more
May 17, 2021

HIV Trial in Saint Louis, Rochester, Seattle (Aluminum hydroxide, Lipid A, Monophosphoryl, Lipid A, Liposome-encapsulated

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +7 more
  • Saint Louis, Missouri
  • +2 more
Oct 28, 2021

Type I Hypersensitivity Trial in Mississauga (Tree MATA MPL - Therapeutic Regimen, Tree MATA MPL - Intermediate dose, Tree MATA

Completed
  • Type I Hypersensitivity
  • Tree MATA MPL - Therapeutic Regimen
  • +3 more
  • Mississauga, Ontario, Canada
    Allied Research International Inc.
Feb 5, 2021

HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

Active, not recruiting
  • HIV-1-infection
  • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam University Medical Centers, location AMC
Jan 31, 2023

Coronavirus Disease 2019 Vaccine in Hemodialysis Patients

Completed
  • Coronavirus Disease 2019 Vaccines
  • Renal Dialysis
    • Buenos Aires, Caba, Argentina
      Universidad de Buenos Aires Facultad de Medicina
    Aug 4, 2022

    Immunity Against COVID-19 Vaccine in Healthcare Workers in

    Active, not recruiting
    • Coronavirus 2019
    • +2 more
    • Immunoglobulin G detection
    • Buenos Aires, Caba, Argentina
      Hospital Italiano de Buenos Aires
    Aug 1, 2022

    Gastroenteritis Trial in Silver Springs, Saint Louis, Rochester (NoV GI.1/GII.4 Bivalent VLP Vaccine, Saline)

    Completed
    Has Results
    • Gastroenteritis
    • NoV GI.1/GII.4 Bivalent VLP Vaccine
    • Saline
    • Silver Springs, Maryland
    • +2 more
    Apr 27, 2018

    HIV Trial in Bangkok (IHV01, A244, ALFQ)

    Recruiting
    • HIV
    • IHV01
    • +3 more
    • Bangkok, Thailand
    • +1 more
    Feb 15, 2022

    Induced by Allergy Immunotherapy (AIT) With Different Adjuvants

    Completed
    • Allergic Rhinitis
    • Allergovit
    • +2 more
    • Zurich, Switzerland
      Univeristy Hospital Zurich
    Mar 22, 2022

    HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

    Not yet recruiting
    • HIV-1-infection
    • VRC07-523LS
    • +7 more
    • Pathum Wan, Bangkok, Thailand
    • +1 more
    Mar 8, 2023

    Sputnik V Vaccine in Health Personnel of Private Effectors of

    Completed
    • COVID-19
      • Buenos Aires, Caba, Argentina
        Hospital Italiano de Buenos Aires
      Aug 24, 2021

      Positron-Emission Tomography, Immunization Reaction Trial (Immunization)

      Completed
      • Positron-Emission Tomography
      • Immunization Reaction
      • Immunization
      • (no location specified)
      Sep 8, 2020

      Allergic Rhinitis, Asthma, Latent Tuberculosis Trial in Paddington (Poly ICLC, Poly I:C, R848)

      Completed
      Has Results
      • Allergic Rhinitis
      • +2 more
      • Poly ICLC
      • +5 more
      • Paddington, London, United Kingdom
        Imperial Clinical Respiratory Research Unit (ICRRU), St Mary's H
      Nov 3, 2021

      Healthy Adults Trial (Drep-HIV-PT1 0.2mg and CN54gp140/MPLA-L, DREP-HIV-PT1 1mg and CN54gp140/MPLA-L (see above), DNA-HIV-PT123

      Not yet recruiting
      • Healthy Adults
      • Drep-HIV-PT1 0.2mg and CN54gp140/MPLA-L
      • +2 more
      • (no location specified)
      Apr 9, 2021

      Metabolism Disorder, Glucose, Metabolism Disorder, Lipid, Vitiligo Trial in Xi'an (Collecting blood samples)

      Completed
      • Metabolism Disorder, Glucose
      • +2 more
      • Collecting blood samples
      • Xi'an, Shaanxi, China
        Xijing Hospital
      Jul 21, 2023

      Acute Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome Trial (Tafolecimab, Cholesterol Absorption Inhibitor,

      Not yet recruiting
      • Acute Coronary Syndrome
      • Non ST Segment Elevation Acute Coronary Syndrome
      • (no location specified)
      Oct 20, 2023

      Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia Trial in Yongin (Evolocumab 140 MG/ML, Rosuvastatin 5mg, Ezetimibe 10mg)

      Recruiting
      • Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia
      • Evolocumab 140 MG/ML
      • +2 more
      • Yongin, Gyeonggi-do, Korea, Republic of
        Yongcheol Kim
      Jan 6, 2023

      Hypertriglyceridemia Trial in Tehran (Control, Omega-3 supplementation, Chia seed)

      Not yet recruiting
      • Hypertriglyceridemia
      • Control
      • +2 more
      • Tehran, Iran, Islamic Republic of
        Clinical Nutrition Research Unit, National Nutrition and Food Te
      Sep 3, 2023

      Postoperative Dyslipidemia and Organ Rejection in Transplant

      Recruiting
      • Heart Transplant Failure and Rejection
        • Wuhan, China
          Wuhan Union Hospital
        Aug 8, 2023

        Dry Eye Trial in Berkeley (Systane Complete PF, Refresh Relieva PF, Refresh Optive Mega-3 PF)

        Not yet recruiting
        • Dry Eye
        • Systane Complete PF
        • +3 more
        • Berkeley, California
          Clinical Research Center, School of Optometry, University of Cal
        Jan 20, 2023

        Asmd, Visceral Type Trial in Amsterdam (MR Spectroscopy (MRS), MR Elastography (MRE))

        Recruiting
        • Asmd, Visceral Type
        • MR Spectroscopy (MRS)
        • MR Elastography (MRE)
        • Amsterdam, Noord-Holland, Netherlands
          Amsterdam UMC
        Jun 6, 2023

        ASCVD, Coronary Artery Calcification Trial (Notification of patients and clinicians)

        Not yet recruiting
        • ASCVD
        • Coronary Artery Calcification
        • Notification of patients and clinicians
        • (no location specified)
        May 5, 2023

        Inclisiran Plus Standard of Care Lipid-lowering Therapy Compared

        Recruiting
        • Primary Hypercholesterolemia
        • Mixed Dyslipidemia
        • Inclisiran
        • Geneve 14, Switzerland
          Novartis Investigative Site
        Nov 14, 2022